“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”

Title
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”
Authors
Keywords
COVID-19, SARS-CoV-2, Vitamin D, Vitamin D3 or cholecalciferol, Calcifediol or 25-hydroxyvitamin D3, 1α, 25(OH)2D or 1α, 25-dihydroxyvitamin D or calcitriol, Acute respiratory distress syndrome (ARDS), Cytokine/Chemokine storm, Renin-angiotensin system, Hypercoagulability, Hydroxychloroquine, Chloroquine, Covidiol, Neutrophil activity, Vitamin D endocrine system, Cuboidal alveolar coating cells type II, Cathelicidin peptide, Defensins, TLR co-receptor CD14, Vitamin D receptor
Journal
Publisher
Elsevier BV
Online
2020-08-29
DOI
10.1016/j.jsbmb.2020.105751

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More